交易中 09-20 14:34:13 美东时间
+0.024
+2.67%
Lineage Cell Therapeutics : Craig-Hallum Initiates Coverage With Buy Rating and...
08-20 19:12
Lineage Cell Therapeutics Inc: Cash Expected to Support Planned Operations Into...
08-09 04:28
Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and P...
08-01 20:00
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that the Company has been added as a
07-02 20:08
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
05-12 00:00
Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 33.33 percent decrease over losses of $(0.03) per share from the same period last
05-10 05:03
Lineage Cell Therapeutics (NYSE:LCTX) announced on Monday the passing of its chairman of the board of directors, Alfred Kingsley. According to LCTX, Kingsley had served as chairman of the company's bo...
04-30 04:39
12月31日,Lineage Cell Therapeutics, Inc.(LCTX.US)公布财报,公告显示公司2023财年净利润为-21.49百万美元,同...
03-10 00:24
Lineage Cell Therapeutics (AMEX:LCTX) reported its Q4 earnings results on Thurs...
03-08 05:05
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
03-07 17:49